Clincosm LogoSign in Get a demo

relapsing polychondritis

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Relapsing Polychondritis : Diagnosis and Management

Recruiting
  • Relapsing Polychondritis
    • Strasbourg, France
      Service de Pédiatrie 1 - CHU de Strasbourg - France
    Aug 24, 2023

    Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

    Recruiting
    • Takayasu's Arteritis
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Longitudinal Study for Relapsing Polychondritis

      Recruiting
      • Relapsing Polychondritis
      • Vasculitis
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Jul 11, 2022

        Giant Cell Arteritis, Takayasu Arteritis, Cogan Syndrome Trial in Cambridge, Glasgow, London (Rituximab, Infliximab,

        Recruiting
        • Giant Cell Arteritis
        • +8 more
        • Rituximab
        • +2 more
        • Cambridge, United Kingdom
        • +2 more
        Dec 9, 2021

        Relapsing Polychondritis Trial in Ottawa (Tocilizumab)

        Completed
        Has Results
        • Relapsing Polychondritis
        • Ottawa, Ontario, Canada
          Children's Hospital of Eastern Ontario
        Feb 11, 2021

        Relapsing Polychondritis Trial (Interleukin-2)

        Unknown status
        • Relapsing Polychondritis
        • (no location specified)
        Sep 1, 2019

        Relapsing Polychondritis Trial in Hamilton (Tocilizumab)

        Withdrawn
        • Relapsing Polychondritis
        • Hamilton, Ontario, Canada
          McMaster Children's Hospital
        May 12, 2014

        Relapsing Polychondritis Trial in Seattle (Abatacept)

        Completed
        • Relapsing Polychondritis
        • Seattle, Washington
          Virginia Mason Medical Center
        Aug 3, 2012